Five-year recurrence-free rates of 89.4% and 83.9% indicate durable disease control after ProSense cryoablation in localized ...

ProKidney Corp., a clinical-stage biotechnology company based in North Carolina, is developing a first-in-class cell therapy for chronic kidney disease (CKD) that experts say could significantly ...

Continued FDA approval of iptacopan was contingent on 2-year trial data ...

Kidney disease treatment is undergoing a transformation, driven by exciting new research that reveals the protective power of semaglutide in patients with type 2 diabetes. Semaglutide, a medication ...

Among patients with hypogonadism and diabetes, testosterone therapy was associated with lower risks for acute kidney injury and all-cause mortality. Testosterone therapy is associated with reductions ...

R1 Therapeutics is debuting with an oversubscribed $77.5 million series A financing aimed at advancing its first-in-class therapy for chronic kidney disease (CKD) patients on dialysis with high ...

Medeor Therapeutics’ kidney transplant cell therapy, which combines a living donor’s cells with the recipient's, allowed more than half of study participants in a phase 3 pivotal trial to stay off ...

Cancer therapies can trigger diverse kidney pathologies, so kidney biopsy is critical for management, according to investigators. Kidney biopsy should be considered in every patient who develops ...

Kidney failure, also known as end-stage renal disease (ESRD), occurs when kidneys lose their ability to filter waste and excess fluids from the blood effectively. This serious condition affects ...

The 2026 PSMA & Beyond conference featured a session on challenges of radioligand therapy and a presentation by Dr. Inès Camille Azrour discussing renal toxicity associated with PSMA targeted therapy.

Dialyzers Segment to Lead Hemodialysis Equipment Market Based on Product During 2025–2031New York, NY, March 31, 2026 (GLOBE ...